Health
Transforming CIDP Management with Subcutaneous Immunoglobulin Therapy
Subcutaneous immunoglobulin (SCIg) therapy has revolutionized the management of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) with its innovative approach. Offering a blend of convenience, cost-effectiveness, and customization, SCIg provides an attractive alternative to traditional intravenous treatments. As effectiveness matches that of IVIg, the added benefits of home administration, flexible dosing, and enhanced patient satisfaction make SCIg […]
3 minute read